These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 204971)
1. [Intermittent chemotherapy from the beginning or only after a period of daily administration? Quantitative bacteriological study at the initial phase of chemotherapy with INH + RMP + EMB in daily or intermittent administration]. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(4):193-205. PubMed ID: 204971 [TBL] [Abstract][Full Text] [Related]
3. [Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)]. Anastasatu C; Bercea O; Barcan F; Stinghe R; Dinulică E; Marcovici M; Cristea M; Cărpinişan L; Gheorghiu M; Iancovici O; Ghinescu S Ftiziologia; 1974 May; 23(3):253-64. PubMed ID: 4842931 [No Abstract] [Full Text] [Related]
4. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis. Long MW; Snider DE; Farer LS Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184 [TBL] [Abstract][Full Text] [Related]
5. Factors influencing the effects of the initial phase of tuberculosis chemotherapy. Tousek J; Zítková L; Trnka L; Staflová S; Papezová E; Drápela J Czech Med; 1980; 3(2):114-22. PubMed ID: 7418568 [TBL] [Abstract][Full Text] [Related]
6. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448 [TBL] [Abstract][Full Text] [Related]
7. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
8. The clearance of theophylline is increased during the initial period of tuberculosis treatment. Ahn HC; Lee YC Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of new and chronic tuberculous patients with ethambutol and Rifampicin (author's transl)]. Pregowski W; Stanczuk A; Znaniecka H; Cesarz-Fronczyk M Z Erkr Atmungsorgane; 1976 May; 145(2):220-6. PubMed ID: 983179 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of antituberculosis drugs after oral isolated and simultaneous administration in triple combination. Zítková L; Janků I; Tousek J; Papezová E; Stastná J Czech Med; 1983; 6(4):202-17. PubMed ID: 6420125 [TBL] [Abstract][Full Text] [Related]
11. [Effectivity of intermittent RMP/EMB treatment in patients with chronic pulmonary tuberculosis (author's transl)]. Frenzel I; Neumeyer D Z Erkr Atmungsorgane; 1976 Aug; 146(2):145-52. PubMed ID: 1020361 [TBL] [Abstract][Full Text] [Related]
12. Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland. Zierski M Scand J Respir Dis Suppl; 1978; 102():48-52. PubMed ID: 278215 [No Abstract] [Full Text] [Related]
13. [A therapeutic trial of a combination of 3 essential drugs in a short course of chemotherapy in tuberculosis. Results 6 months after the end of treatment]. Agounitestane D; Chiheb M; Khaled S; Ait Khaled N; Boulahbal F; Chaulet P Rev Mal Respir; 1990; 7(3):209-13. PubMed ID: 2114029 [TBL] [Abstract][Full Text] [Related]
14. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis]. Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720 [TBL] [Abstract][Full Text] [Related]
15. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up. Su WJ; Perng RP Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151 [TBL] [Abstract][Full Text] [Related]
16. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months. Nolan CM; Goldberg SV Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140 [TBL] [Abstract][Full Text] [Related]
17. [Comparative study (in a controlled therapeutic trial) of 3 intermittent regimens, after an initial period of daily administration, in the repeated treatment of pulmonary tuberculosis (results)]. Fraga H; Gomes O; Paz de Almeida A; Gerhardt G; Santiago AC Bull Int Union Tuberc; 1973 Jun; 48(0):125-38. PubMed ID: 4602467 [No Abstract] [Full Text] [Related]
18. [Studies of resumption of treatment with rifampin and ethambutol in patients with recurrent pulmonary tuberculosis]. Jozefovics F; Barbu Z; Bálinth E; Ovári AM Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978; 27(3):177-84. PubMed ID: 212815 [TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol. Jeanes CW; Jessamine AG; Eidus L Can Med Assoc J; 1972 Apr; 106(8):884-8. PubMed ID: 4623743 [TBL] [Abstract][Full Text] [Related]
20. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation]. Masztalerz J Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043 [No Abstract] [Full Text] [Related] [Next] [New Search]